Susan M. Freier
254Patents
31h-index
138Co-inventors
93Inventor score
Filing activity: Dec 14, 1992 → Nov 29, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6210892A | Alteration of cellular behavior by antisense modulation of mRNA processing | Emerging Cross-Sectional Technologies | 245 | Expired |
| US7321828B2 | System of components for preparing oligonucleotides | Physics | 177 | Expired |
| US7511131B2 | Antisense modulation of apolipoprotein B expression | Emerging Cross-Sectional Technologies | 152 | Expired |
| US7683036B2 | Oligomeric compounds and compositions for use in modulation of small non-coding RNAs | Chemistry; Metallurgy | 130 | Expired |
| US7339051B2 | Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) | Chemistry; Metallurgy | 129 | Expired |
| US7217572B2 | Modulation of HIF1α and HIF2α expression | Chemistry; Metallurgy | 120 | Expired |
| US7235653B2 | Oligonucleotide compositions and methods for the modulation of the expression of B7 protein | Emerging Cross-Sectional Technologies | 112 | Expired |
| US6287860A | Antisense inhibition of MEKK2 expression | Emerging Cross-Sectional Technologies | 103 | Expired |
| US5576208A | Antisense oligonucleotide inhibition of the RAS gene | Chemistry; Metallurgy | 102 | Expired |
| US7399853B2 | Modulation of glucagon receptor expression | Chemistry; Metallurgy | 75 | Expired |
| US6383808B1 | Antisense inhibition of clusterin expression | Emerging Cross-Sectional Technologies | 62 | Expired |
| US8110558B2 | Oligomeric compounds and compositions for use in modulation of small non-coding RNAS | Chemistry; Metallurgy | 58 | Active |
| US9765338B2 | Modulation of dystrophia myotonica-protein kinase (DMPK) expression | Chemistry; Metallurgy | 57 | Active |
| US5582986A | Antisense oligonucleotide inhibition of the ras gene | Chemistry; Metallurgy | 54 | Expired |
| US6455308B1 | Antisense modulation of serum amyloid A4 expression | Emerging Cross-Sectional Technologies | 50 | Expired |
| US6359124B1 | Antisense inhibition of ras gene with chimeric and alternating oligonucleotides | Chemistry; Metallurgy | 45 | Expired |
| US5965722A | Antisense inhibition of ras gene with chimeric and alternating oligonucleotides | Chemistry; Metallurgy | 45 | Expired |
| US7951934B2 | Compositions and their uses directed to huntingtin | Chemistry; Metallurgy | 45 | Active |
| US8093222B2 | Methods for treating hypercholesterolemia | Chemistry; Metallurgy | 43 | Active |
| US8084437B2 | Methods for treating hypercholesterolemia | Chemistry; Metallurgy | 41 | Active |
| US8133876B2 | Oligomeric compounds and compositions for use in modulation of small non-coding RNAs | Chemistry; Metallurgy | 41 | Active |
| US8106025B2 | Method for inhibiting the activity of mir-155 | Chemistry; Metallurgy | 40 | Active |
| US5582972A | Antisense oligonucleotides to the RAS gene | Chemistry; Metallurgy | 39 | Expired |
| US8957040B2 | Selective reduction of allelic variants | Chemistry; Metallurgy | 39 | Active |
| US7803930B2 | Antisense modulation of apolipoprotein B-expression | Emerging Cross-Sectional Technologies | 38 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.